GRI Bio(GRI)
$1.120.00 (0.00%)
GRI
GRI Bio financials statements
$1.12
At close:0.00 (0.00%)
Want to see GRI full AI Analyst Report?
GRI Bio (GRI) Ratios
370 Followers
GRI Bio Ratios
GRI's free cash flow for Q3 2026 was $-1.48M. For the 2026 fiscal year, GRI's free cash flow was increased by $0.00 and operating cash flow was $-1.48M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.25 | 3.43 | 1.09 | 0.16 | 0.02 |
| Quick Ratio | 3.25 | 3.43 | 1.09 | 0.16 | 0.02 |
| Cash Ratio | 3.11 | 3.07 | 0.67 | 0.00 | 0.02 |
| Solvency Ratio | -4.50 | -4.81 | -4.81 | -1.58 | -1.87 |
| Operating Cash Flow Ratio | -3.85 | -5.26 | -3.33 | -0.54 | -0.17 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | -1.80 | -0.24 |
| Net Current Asset Value | $ 5.93M | $ 3.91M | $ 237.00K | $ -1.70M | $ -4.85M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.02 | 0.00 | 1.76 | 16.58 |
| Debt-to-Equity Ratio | 0.01 | 0.03 | 0.05 | -0.41 | -0.77 |
| Debt-to-Capital Ratio | 0.01 | 0.03 | 0.05 | -0.71 | -3.26 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.44 | 1.42 | 11.41 | -0.24 | -0.05 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | -5.23 | -2.00 | -2.62 |
| Interest Coverage Ratio | 0.00 | 0.00 | -5.47 | -3.43 | -578.69 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.72 | 18.18 | 1328.26 | 1143.10 | 312.88 |
| Net Debt to EBITDA | 0.68 | 0.60 | 0.16 | -0.26 | -0.38 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | -0.02% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | -36.41% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | -36.40% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | -36.54% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | -36.41% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | -36.41% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | -36.41% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 99.82% | 99.66% | 114.49% | 143.68% | 100.48% |
| Return on Assets (ROA) | -137.96% | -143.00% | -441.04% | -839.95% | -4267.43% |
| Return on Equity (ROE) | -199.00% | -203.55% | -5033.59% | 197.97% | 196.93% |
| Return on Capital Employed (ROCE) | -198.85% | -200.71% | -4396.53% | 138.98% | 198.82% |
| Return on Invested Capital (ROIC) | -197.02% | -198.39% | -4171.06% | 235.19% | 834.14% |
| Return on Tangible Assets | -137.96% | -143.00% | -441.04% | -839.95% | -4267.43% |
| Earnings Yield | -1762.64% | -318.02% | -49.55% | -0.74% | -0.01% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.04 | 0.04 | 1.28 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 181.76 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 3.93 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 10.69 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -81851.25 | -9028.95 | -9446.20 | -285.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 81851.25 | 9028.95 | 9446.20 | 285.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -103.77 | -1315.46 | -5697.08 | -935.34 | -73.00 |
| Free Cash Flow Per Share | -103.80 | -1315.46 | -5702.15 | -937.93 | -73.00 |
| Dividend Paid and CapEx Coverage Ratio | -3395.33 | 0.00 | -1123.75 | -361.67 | 0.00 |
| Capital Expenditure Coverage Ratio | -3395.33 | 0.00 | -1123.75 | -361.67 | 0.00 |
| Operating Cash Flow Coverage Ratio | -143.46 | -72.36 | -642.14 | -1.61 | -0.23 |
| Operating Cash Flow to Sales Ratio | 0.00 | -0.38 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -1502.14% | -333.67% | -34.20% | -0.25% | -0.00% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.06 | -0.26 | -2.02 | -135.89 | -9691.27 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.11 | 0.64 | 101.59 | -269.01 | -19085.07 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.07 | -0.30 | -2.92 | -401.79 | -106443.77 |
| Price-to-Operating Cash Flow Ratio | -0.07 | -0.30 | -2.93 | -402.90 | -106443.77 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.00 | -0.01 | -0.09 | 243.71 |
| Enterprise Value Multiple | 0.62 | 0.28 | -2.25 | -174.15 | -9785.26 |
| Enterprise Value | -7.48M | -2.33M | 24.52M | 437.81M | 90.16B |
| EV to EBITDA | 0.62 | 0.28 | -2.25 | -174.15 | -9785.26 |
| EV to Sales | 0.00 | -0.10 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | 0.73 | 0.27 | -2.72 | -402.40 | -106447.93 |
| EV to Operating Cash Flow | 0.73 | 0.27 | -2.73 | -403.51 | -106447.93 |
| Tangible Book Value Per Share | 61.20 | 615.95 | 164.13 | -1400.86 | -407.17 |
| Shareholders’ Equity Per Share | 61.20 | 615.95 | 164.13 | -1400.86 | -407.17 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 3443.02 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -121.80 | -1253.74 | -8261.72 | -2773.28 | -801.84 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.19 | 1.25 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.17 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.20 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.85 | 1.05 | 0.69 | 0.34 | 0.54 |
Currency in USD
